Needham & Company Starts Clearside Biomedical (CLSD) at Buy
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Wall St ends mixed as tech megacap declines outweigh upbeat chip outlook
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- IBM surges on unveiling sub-1nm chip technology breakthrough
- 'Long-term deals significant positive for stock:' Analysts react to Micron results
- Two major earthquakes strike Venezuela, killing at least 32 and injuring hundreds
- Needham Starts NeoVolta (NEOV) at Buy
- Rockstar Games opens GTA VI pre-orders, priced at $79.99
- Rubio meets Gulf leaders, pledges security amid Iran deal doubts
- Hertz cuts guidance, announces notes and stock offerings, shares sink
Cowen Starts Clearside Biomedical (CLSD) at Outperform
June 27, 2016 6:46 AM EDTCowen initiated coverage on Clearside Biomedical (NASDAQ: CLSD) with an Outperform rating.
For an analyst ratings summary and ratings history on Clearside Biomedical click here. For more ratings news on Clearside Biomedical click here.
Shares of Clearside Biomedical closed at $6.80 yesterday.
... MoreWedbush Starts Clearside Biomedical (CLSD) at Outperform, $28 PT
June 27, 2016 6:20 AM EDTWedbush initiates coverage on Clearside Biomedical (NASDAQ: CLSD) with a Outperform rating and a price target of $28.00.
Analyst Liana Moussatos commented, "We believe an investment in CLSD supports a dramatic improvement in injectable drug delivery for multiple eye diseases."
She added, "Clearside is a... More
